AzTrials
AzTrials

MyopiaNCT05611294

Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction

A study testing Topography Guided LASIK Surgery and Small Incision Lenticule Extraction Surgery in people with Myopia and Astigmatism, run by Hoopes Vision at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study evaluates differences in postoperative visual outcomes between patients receiving Topography-Guided LASIK in one eye and Small Incision Lenticule Extraction in the other eye. Read more about this study

Who is it for?
Ages 22 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Myopia, Astigmatism
What is being tested?
Topography Guided LASIK Surgery and Small Incision Lenticule Extraction Surgery
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteUnited States
Study dates
27 Sep 2022to 1 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age 22-50 at the time of consent
  • Diagnosis of myopia or myopia with astigmatism with Preop manifest spherical equivalent of refraction of ≥ -2.00 and ≤ -9.00 D
  • Preop Spherical component of ≥ -2.00 and ≤ -8.00 D
  • Refractive Cylinder of ≤ -3.00 D
  • BCVA of 20/20 or better in each eye
  • Subjects must have a stable refraction which is defined as change in spherical equivalent no greater than 0.50 D comparing screening visit manifest refraction to previous refractions over one year period prior to surgery. (spectacle Rx, or contact lens Rx)
Show all 12Show fewer
  • Subjects who are contact lens wearers must have hard or gas permeable lenses discontinued for at least 4 weeks and soft lenses discontinued for at least 5 days prior to the preoperative screening evaluation. Hard or gas permeable lens wearers must not return to contact lens use before surgery and soft lens wearers must discontinue use at least 5 days before surgery.
  • Acceptable topography and baseline examination results for refractive procedures as determined by Principal Investigator or Co-Investigator
  • Surgical plan includes treatment target for emmetropia in both eyes and no monovision.
  • Subject is capable and willing to use postoperative medications as prescribed.
  • Subject has ability to successfully complete all preoperative and postoperative questionnaires, testing, and exam visits.
  • Subjects are willing and able to return for all postoperative examinations.

Who cannot join

  • Clinically significant dry eye on clinical examination as determined by the investigator
  • Irregular astigmatism, keratoconus, keratoconus suspect, or abnormal corneal topography
  • History of corneal dystrophies or guttata
  • History of herpetic keratitis or active disease
  • History of prior refractive surgery
  • History of glaucoma or glaucoma suspect
Show all 9Show fewer
  • History of uncontrolled diabetes, unstable hypertension, or unstable autoimmune disease.
  • Females who are pregnant, breast-feeding, or intend to become pregnant any time during the course of the study as determined by verbal inquiry.
  • The Principal Investigator has determined the subject not to be a good candidate for the study

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Hoopes Vision

    Draper, Utah, 84020

Other trials in United States

About this study

Official title: A Visual Outcome Comparison of Topography Guided LASIK Versus Small Incision Lenticule Extraction: A Prospective Contralateral Eye Study

This study evaluates differences in postoperative visual outcomes between patients receiving Topography-Guided LASIK in one eye and Small Incision Lenticule Extraction in the other eye.

Read the detailed description

This is a prospective, randomized, simultaneous, contralateral eye study including at least 42 patients undergoing refractive correction surgery. Patients will be selected from the Hoopes Vision patient population after a preliminary refractive evaluation has been completed. Patients who express an interest in the study will be consented. After informed consent has been obtained and the patient has completed a screening exam and met all study criteria they will be considered enrolled. Randomization will ensure 50% of Right Eyes will receive Topography-Guided LASIK and 50% of Right Eyes will receive Small Incision Lenticule Extraction. Subjects will be given postoperative care instructions and medications following standard of care practices. Subjects will return for a 1-day, 1-week, 1-month, 3-month, and 12-month visit. Retreatments may only occur after all postoperative study visits have been completed and/or the subject has exited the study. At the preliminary screening visit, 1-month, 3-month, and 12-mont postoperative visits, patients will complete a Patient Participant Questionnaire.

Conditions
Myopia, Astigmatism
Being tested
Topography Guided LASIK Surgery, Small Incision Lenticule Extraction Surgery
Keywords
refractive surgery, myopia, astigmatism, excimer laser, femtosecond laser, VARIO Topolyzer, Lenticule
Medical subject headings
Myopia, Astigmatism

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Topography Guided LASIK SurgeryDevice

    LASIK surgery, using corneal topography data in treatment profile, to correct myopia or myopia with astigmatism refractive error.

  • Small Incision Lenticule Extraction SurgeryDevice

    Corneal lenticule formation using a femtosecond laser, with subsequent lenticule extraction, to correct myopia or myopia with astigmatism refractive error.

Study groups in NCT05611294
Study groupRoleWhat they receive
Topography-Guided LASIKActive comparatorSubjects receive Topography-Guided LASIK surgery on one eye.
Receives: Device: Topography Guided LASIK Surgery
Small Incision Lenticule ExtractionActive comparatorSubjects receive Small Incision Lenticule Extraction surgery on one eye.
Receives: Device: Small Incision Lenticule Extraction Surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Uncorrected Visual Acuity

    Percentage of eyes with Uncorrected Visual Acuity of 20/20 or better

    Measured: 12 months

  2. Corrected Visual Acuity

    Percentage of eyes with Corrected Visual Acuity of 20/20 or better

    Measured: 12 months

Secondary outcomes (1)
  1. Predictability of Intended Outcome

    Percentage of eyes with refractive error within +/- 0.50 D MRSE and +/- 1.00 D MRSE of intended correction

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2022
  2. Study start27 Sep 2022
  3. Primary completion1 May 2025 (estimated)
  4. Study completion1 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Contralateral Eye to Eye Comparison
Masking
None (open label)
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05611294
Sponsor's protocol ID
HDRR-CON2022
Status last verified
Jul 2024
First submitted
27 Oct 2022
Last updated
1 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: No individual participant data will be shared with other researchers outside of those participating in this specific study.

Publications

  • Moin KA, Manion GN, Pandiri S, Hoopes PC, Moshirfar M. Three-Month Comprehensive Outcomes of Topography-Guided LASIK Versus Keratorefractive Lenticule Extraction (KLEx): A Prospective Contralateral Study. Ophthalmol Ther. 2024 Aug;13(8):2265-2284. doi: 10.1007/s40123-024-00987-y. Epub 2024 Jul 1.

    PubMed 38951314

Questions about this trial

What is this clinical trial studying?

A study testing Topography Guided LASIK Surgery and Small Incision Lenticule Extraction Surgery in people with Myopia and Astigmatism, run by Hoopes Vision at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Uncorrected Visual Acuity (time frame: 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05611294, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in